Poison Ivy (Gotham City Sirens) Art Scale 1/10 statue

Sale priceRs. 15,499.00 Regular priceRs. 19,999.00

Driven by an obsession for plants, botany, and extremist environmentalism, with the desire to save the world from the evils of men at any cost, Pamela is a genius scientist and a metahuman with a hybrid plant DNA, using mutant plants, pheromones, and toxins from plants and from her own blood for her criminal activities.

Exploring the statue:
Over an old and decomposed wooden floor, the beautiful and seductive redhead psycho-eco-terrorist slides over plants, flowers, and vegetable tentacle, over a rotten wooden floor. Tied to the interplanetary force known as The Green, she has supernatural control over the life of plants and, wearing an emerald dress decorated with purple and red flowers, her ability to emit pheromones that can control minds make her one of the most dangerous supervillains. Iron Studios present the statue “Poison Ivy (Gotham City Sirens) - DC Comics - Art Scale 1/10", inspired by the Gotham City Sirens comic books reimagined by Iron Studios.

Iron Studios also bring the Deluxe version of the statue “Poison Ivy (Gotham City Sirens) Deluxe - DC Comics - Art Scale 1/10”, with the supervillain over a base filled with loot such as doubloons and gold bars, a doll of her best friend and recurring ally Harley Quinn, kittens that are a reference to another protagonist of the city, etc., where she positions herself on top of a huge mutant vegetable tentacle covered by big spikes, connected to a carnivorous flowers filled with fangs, another creation of her insanity.

Figure details:
Poison Ivy (Gotham City Sirens) - DC Comics - Art Scale 1/10 measurements are 8.8 in (H) x 4.1 in (W) x 4.3 in (D) - 1.3 lbs, which allows an impressive presentation of the statue in any environment.

Special features:
The statue Poison Ivy (Gotham City Sirens) – DC Comics – Art Scale 1/10 from Iron Studios will be produced in limited edition. The diorama base present rich details inspired by the original references.

ETA: Q1, 2025